SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic

• Egile Nagusiak: Ali A. Rabaan (Egilea), Shamsah H. Al-Ahmed (Egilea), Ranjit Sah (Egilea), Ruchi Tiwari (Egilea), Mohd. Iqbal Yatoo (Egilea), Shailesh Kumar Patel (Egilea), Mamta Pathak (Egilea), Yashpal Singh Malik (Egilea), Kuldeep Dhama (Egilea), Karam Pal Singh (Egilea), D. Katterine Bonilla-Aldana (Egilea), Shafiul Haque (Egilea), Dayron F. Martinez-Pulgarin (Egilea), Alfonso J. Rodriguez-Morales (Egilea), Hakan Leblebicioglu (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2020-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract A novel coronavirus (SARS-CoV-2), causing an emerging coronavirus disease (COVID-19), first detected in Wuhan City, Hubei Province, China, which has taken a catastrophic turn with high toll rates in China and subsequently spreading across the globe. The rapid spread of this virus to more th...